Response: Re: An Estimate of Severe Harms Due to Screening Colonoscopy: A Systematic Review

References

1. 1.↵
   1. Swartz AW,
   2. Klippenstein K,
   3. Lavender D

   . Re: An estimate of severe harms due to screening colonoscopy: a systematic review [letter to the editor]. J Am Board Fam Med 2023;36:xxx.

   OpenUrl
2. 2.↵
   1. Huffstetler AN,
   2. Fraiman J,
   3. Brownlee S,
   4. Stoto MA,
   5. Lin KW

   . An estimate of severe harms due to screening colonoscopy: a systematic review. J Am Board Fam Med 2023;36:493–500.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Lin JS,
   2. Perdue LA,
   3. Henrikson NB,
   4. et al

   . Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021;325:1978–98.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Kothari ST,
   2. Huang RJ,
   3. Shaukat A,
   4. et al

   . ASGE review of adverse events in colonoscopy. Gastrointest Endosc 2019;90:863–76.e33.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Page MJ,
   2. et al

   . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.

   OpenUrlFREE Full Text
6. 6.↵
   1. Quintero E,
   2. Castells A,
   3. Bujanda L,
   4. et al

   . Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697–706.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Forsberg A,
   2. Westerberg M,
   3. Metcalfe C,
   4. et al

   . Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial. Lancet Gastroenterol Hepatol 2022;7:513–21.

   OpenUrl